Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal StriatumEstefanía Moreno, Manuel Guzmán, Marı́a José Casarejos et al.|Neuropsychopharmacology|2017Cited by 67
Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's diseaseDavid Moreno‐Delgado, Peter J. McCormick, Mar Puigdellívol et al.|eLife|2020Cited by 33
Author response: Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's diseaseDavid Moreno‐Delgado, Peter J. McCormick, Mar Puigdellívol et al.|Unknown|2020Cited by 1
Modulation of dopamine D <sub>1</sub> receptors via histamine H <sub>3</sub> receptors is a novel therapeutic target for Huntington’s diseaseDavid Moreno‐Delgado, Peter J. McCormick, Mar Puigdellívol et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 0